Human Genome Epidemiology Literature Finder
|
Records 1 - 3 (of 3 Records) |
| Query Trace: Anemia and SLC28A2[original query] |
|---|
| Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C. Pharmacogenetics and genomics 2011 May 21 (5): 289-96. Doehring Alexandra, Hofmann Wolf Peter, Schlecker Christina, Zeuzem Stefan, Sarrazin Christoph, Berg Thomas, Müller Tobias, Herrmann Eva, Geisslinger Gerd, Lötsch Jö |
| Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. Journal of hepatology 2013 Apr 58 (4): 669-75. Rau Monika, Stickel Felix, Russmann Stefan, Manser Christine N, Becker Philip P, Weisskopf Michael, Schmitt Johannes, Dill Michael T, Dufour Jean-François, Moradpour Darius, Semela David, Müllhaupt Beat, Geier Andreas, |
Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2021 Sep 143 112195. Lin Jennifer J, Loucks Catrina M, Trueman Jessica N, Drögemöller Britt I, Wright Galen E B, Yoshida Eric M, Ford Jo-Ann, Lee Samuel S, Kim Richard B, Al-Judaibi Bandar, Schwarz Ute I, Ramji Alnoor, Tam Edward, Ross Colin J, Carleton Bruce |
- Page last reviewed:Feb 1, 2024
- Content source: